New Use for Semaglutide Recent research has shown that the popular GLP-1 weight loss drug, semaglutide, may halt and even reverse severe liver disease in some patients
The pharmaceutical sector itself accounts for 41.7% of the BWFI application demand, driven by its extensive use in preparing biologics, vaccines, and other research compounds
Moreover, patients with T2DM have impaired incretin action, which highlights GLP-1 as a useful pharmacotherapy for restoring glucose control (reviewed in Madsbad, GLP-1R agonists The GLP-1R agonists mediate their action by acting directly on the GLP-1R
While absolute incidence of NAION is low in patients initiating semaglutide, medical counseling about this potential complication, which can result in substantial loss of vision, may be warranted, the authors wrote
This expands the evidenced patient population for semaglutide significantly
Recent data has shown that some women taking GLP-1 receptor agonists report improvements in their menstrual cycles